Shiro Kunito

Suggest Changes
  • Citations Per Year
Learn More
AIM Several previous reports showed that irinotecan hydrochloride plus cisplatin (CPT-P) was a candidate first-line chemotherapy regimen for clear cell adenocarcinoma of the ovary (CCC). However,(More)
  • 1